Senseonics Holdings Inc.
Research Senseonics Holdings Inc. (6L60) on Bullrun: market cap EUR 425.64M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6L60
- ExchangeF
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 425.64M
- Financial periodQ2 2026
- RevenueUSD 14.48M
- Net income-USD 36.71M
- Free cash flow-USD 30.36M
- Gross margin59.1%
Valuation Snapshot
latest market cap is EUR 425.64M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 35.26M | -USD 69.11M | -USD 60.25M | 44.7% | n/a | USD 40.23M | USD 41.37M | USD 61.05M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 425.64M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Senseonics Holdings Inc.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Senseonics Holdings Inc.'s market cap?
Senseonics Holdings Inc.'s market capitalization is EUR 425.64M.
What does Senseonics Holdings Inc. do?
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.